Triangle Securities Wealth Management raised its stake in Danaher Co. (NYSE:DHR – Free Report) by 62.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,746 shares of the conglomerate’s stock after buying an additional 1,440 shares during the period. Triangle Securities Wealth Management’s holdings in Danaher were worth $860,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Benjamin Edwards Inc. lifted its stake in Danaher by 1.8% in the second quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock worth $538,000 after purchasing an additional 38 shares during the last quarter. Wedge Capital Management L L P NC increased its holdings in shares of Danaher by 3.2% in the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock worth $342,000 after buying an additional 38 shares during the period. Certified Advisory Corp lifted its stake in shares of Danaher by 4.5% in the 2nd quarter. Certified Advisory Corp now owns 926 shares of the conglomerate’s stock valued at $231,000 after acquiring an additional 40 shares during the last quarter. Meridian Financial Partners LLC boosted its holdings in Danaher by 4.4% during the 3rd quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock valued at $266,000 after acquiring an additional 40 shares during the period. Finally, Kovack Advisors Inc. grew its position in Danaher by 3.4% during the 3rd quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after acquiring an additional 41 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on DHR shares. Stephens reissued an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. KeyCorp upped their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Citigroup dropped their target price on shares of Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a report on Monday, January 6th. Scotiabank initiated coverage on Danaher in a report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Finally, Raymond James dropped their price objective on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a report on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $286.80.
Danaher Price Performance
Shares of NYSE DHR opened at $238.41 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The company has a 50 day simple moving average of $234.85 and a two-hundred day simple moving average of $253.32. Danaher Co. has a fifty-two week low of $222.53 and a fifty-two week high of $281.70. The company has a market capitalization of $172.20 billion, a price-to-earnings ratio of 45.50, a P/E/G ratio of 4.23 and a beta of 0.83.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter in the previous year, the business earned $2.02 earnings per share. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. Analysts expect that Danaher Co. will post 7.49 EPS for the current fiscal year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.45%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- What Are Dividend Contenders? Investing in Dividend Contenders
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Earnings Per Share Calculator: How to Calculate EPS
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Best Stocks Under $5.00
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.